Bilcare Ltd · NSE:BI

Bilcare — Investor Presentation (October 2011)

19 slides from Bilcare's investor presentation, October 2011

1. Slide 1: Corporate Overview

   Speed | Innovation | Happiness Corporate Overview

2. Slide 2: Contents

   Contents Bilcare Overview Businesses Business Strategy Financial Overview Speed | Innovation | Happiness 2

3. Slide 3: Bilcare Overview

   Bilcare Overview Speed | Innovation | Happiness 3

4. Slide 4: Our Objective

   Bilcare Overview Our Objective Vision Delivering Innovation – Transforming Lives Values Speed Innovation Happiness Proactive and swift action Our constant approach at We are motivated by our is our mantra all levels is to seek better customer's success and ways of listening, thinking happiness of ou

5. Slide 5: Business Overview

   Bilcare Overview Business Overview Market position Revenues Customers Global Footprint People Leading provider of Research Plants in 13 Team of 2300 Over 2500 based USD 550 million locations across strong customers Innovative in revenues Europe, US and professionals globally packaging Asia globally

6. Slide 6: Global Presence

   Bilcare Overview Global Presence Crickhowel, UK Weißandt-Gölzau, Germany Bötzingen, Germany Staufen, Germany Delaware, USA Phoenixville, USA Fucine, Italy Tampa, USA Castglione, Italy Thane, India Singapore Nasik, India Pune, India Speed | Innovation | Happiness 6

7. Slide 7: Corporate Structure

   Bilcare Overview Corporate Structure Bilcare Inc. 100% Bilcare Clinical Bilcare U.K. Supplies (Europe) Ltd. 100% 100% Bilcare Singapore 100% Bilcare Brazil 100% International Labs 50% Bilcare Technologies Bilcare Technologies Italia 80% 92% Bilcare India Bilcare Research Caprihans GmbH 51% 100% Bilc

8. Slide 8: Businesses

   Businesses Speed | Innovation | Happiness 8

9. Slide 9: Business Verticals

   Businesses Business Verticals nonClonableIDTM Bilcare Solutions Global Clinical Supplies Technologies Pharma Packaging Accelerating drug Innovations development process – Anytime, Anywhere Authentication and Track- Solutions for Clinical Trial and-Trace technology for Programs; facilitating speed pe

10. Slide 10: Bilcare Solutions

    Businesses Bilcare Solutions Pharma Packaging Pioneers in providing a wide range of pharmaceutical films & foils, to suit Innovations the sensitivity of the drug and strengthen its brand equity Packaging Films Leading suppliers of wide range of rigid Mono and Multilayer films for Food Solutions & FM

11. Slide 11: Global Clinical Supplies

    Businesses Global Clinical Supplies Bilcare GCS provides:  Protocol design End-to-end clinical supplies  Regulatory compliance & patient safety management services;  Batch manufacturing facilitating speed to market  Packaging design  Clinical packaging and randomization  Storage and global dis

12. Slide 12: nonClonableID Technologies

    Businesses nonClonableIDTM Technologies Wide range of Applications nonClonableIDTM Benefits Anytime, Anywhere Authentication and Track-and- Trace technology for people and  Security & ID Cards  Better visibility throughout the products.  Document Security supply chain  Currency Security  Reliab

13. Slide 13: nonClonableID Technologies: Authentication and Track 'n' Trace

    Businesses nonClonableIDTM Technologies Authentication and Track ‘n’ Trace Anytime, Anywhere How is it made? How does it work? Speed | Innovation | Happiness 13

14. Slide 14: Business Strategy

    Business Strategy Speed | Innovation | Happiness 14

15. Slide 15: Addressing Challenges

    Business Strategy Addressing Challenges Compliance Bilcare Counterfeit Packaging Solutions Communication Convenience Cost Global Regulatory hurdles Clinical R&D and Innovation pipeline deficit Supplies Lack of patient population for enrollment Brand Protection nonClonableIDTM Technologies Lack of Au

16. Slide 16: Financial Overview

    Financial Overview Speed | Innovation | Happiness 16

17. Slide 17: Profit & Loss Statement

    Financial Overview Profit & Loss Statement Crores 31.03.2009 31.03.2010 30.09.2010 Particulars Audited Audited Unaudited (12 months) (12 months) (6 months) Revenue (Including other Income) 863.73 1065.80 787.86 Contribution 389.36 474.71 346.37 % of Revenue 45.08% 44.54% 43.96% Fixed Expenses 195.14

18. Slide 18: Balance Sheet

    Financial Overview Balance Sheet Crores 31.03.2009 31.03.2010 30.09.2010 Particulars Audited Audited Unaudited Equity capital 17.21 22.69 22.69 Net worth (including deferred tax) 553.63 939.89 1489.71 Debt 950.46 599.32 1159.87 Total 1521.30 1561.90 2672.27 Net Fixed Assets 844.35 887.91 1776.29 Inv

19. Slide 19: Thank you!

    Thank you! visit us at www.bilcare.com Speed | Innovation | Happiness 19

Bilcare — Investor Presentation (October 2011) on 6ix